• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishDashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form SC 13G filed by PetMed Express Inc.

    10/10/24 6:26:43 PM ET
    $PETS
    Retail-Drug Stores and Proprietary Stores
    Consumer Staples
    Get the next $PETS alert in real time by email
    SC 13G 1 ea0217351-13gnina_petmed.htm SCHEDULE 13G

     

     

    UNITED STATES

    SECURITIES AND EXCHANGE COMMISSION

    Washington, D.C. 20549

     

     

     

    SCHEDULE 13G

    (Rule 13d-102)

     

    Information to be Included in Statements Filed Pursuant to §240.13d-1(b), (c) and (d) and Amendments Thereto Filed Pursuant to §240.13d-2

     

    Under the Securities Exchange Act of 1934

     

    Petmed Express, Inc.

    (Name of Issuer)

     

    Common Stock, par value $.001 per share

    (Title of Class of Securities)

     

    716382106

    (CUSIP Number)

     

    April 17, 2024

    (Date of Event Which Requires Filing of This Statement)

     

    Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

     

    ☐Rule 13d-1(b)
    ☒Rule 13d-1(c)
    ☐Rule 13d-1(d)

     

     

    *The remainder of this cover page shall be filed out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter disclosures provided in a prior cover page.

     

    The information required on the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (the “Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

     

     

     

     

     

     

    CUSIP No. 716382106 SCHEDULE 13G Page 2 of 9 Pages

     

    1.

    Names of Reporting Persons.

    I.R.S. Identification Nos. of above persons (entities only)

     

    Nina Capital Holdings Inc.

    2. Check the Appropriate Box if a Member of a Group 

    (a) ☒

    (b) ☐

    3.

    SEC Use Only

     

     

    4.

    Citizenship or Place of Organization

     

    British Virgin Islands

    NUMBER OF

    SHARES

    BENEFICIALLY

    OWNED BY

    EACH

    REPORTING

    PERSON WITH

    5.

    Sole Voting Power

     

    0

    6.

    Shared Voting Power

     

    1,550,000

    7.

    Sole Dispositive Power

    0

    8.

    Shared Dispositive Power

     

    1,550,000 

    9.

    Aggregate Amount Owned by Each Reporting Person

     

    1,550,000

    10. Check Box if the Aggregate Amount in Row (9) Excludes Certain Shares  

    ☐

      

    11.

    Percent of Class Represented in Row (9)

     

    7.52%*

    12.

    Type of Reporting Person (See Instructions)

     

    CO

     

    *Based on 20,600,652 shares of Common Stock, $.001 par value per share, at August 7, 2024, as reported on the Issuer’s Form 10-Q as filed with the SEC on August 7, 2024.

     

     

     

     

    CUSIP No. 716382106 SCHEDULE 13G Page 3 of 9 Pages

     

    1.

    Names of Reporting Persons.

    I.R.S. Identification Nos. of above persons (entities only)

     

    Moises Tache Galante

    2. Check the Appropriate Box if a Member of a Group 

    (a) ☒

    (b) ☐

    3.

    SEC Use Only

     

     

    4.

    Citizenship or Place of Organization

     

    Spain

    NUMBER OF

    SHARES

    BENEFICIALLY

    OWNED BY

    EACH

    REPORTING

    PERSON WITH

    5.

    Sole Voting Power

     

    0

    6.

    Shared Voting Power

     

    2,078,000(1)

    7.

    Sole Dispositive Power

    0

    8.

    Shared Dispositive Power

     

    2,078,000(1)

    9.

    Aggregate Amount Owned by Each Reporting Person

     

    2,078,000(1)

    10. Check Box if the Aggregate Amount in Row (9) Excludes Certain Shares  

    ☐

      

    11.

    Percent of Class Represented in Row (9)

     

    10.08%*

    12.

    Type of Reporting Person (See Instructions)

     

    IN

     

    1)Includes (i) 1,550,000 shares of Common Stock held by Nina Capital Holdings, and (ii) 528,000 shares of Common Stock held jointly by Moises Tache Galante and his spouse, Stephannie Matz Zyman.

     

    *Based on 20,600,652 shares of Common Stock, $.001 par value per share, at August 7, 2024, as reported on the Issuer’s Form 10-Q as filed with the SEC on August 7, 2024.

     

     

     

     

    CUSIP No. 716382106 SCHEDULE 13G Page 4 of 9 Pages

     

    1.

    Names of Reporting Persons.

    I.R.S. Identification Nos. of above persons (entities only)

     

    Stephannie Matz Zyman

    2. Check the Appropriate Box if a Member of a Group 

    (a) ☒

    (b) ☐

    3.

    SEC Use Only

     

     

    4.

    Citizenship or Place of Organization

     

    Mexico

    NUMBER OF

    SHARES

    BENEFICIALLY

    OWNED BY

    EACH

    REPORTING

    PERSON WITH

    5.

    Sole Voting Power

     

    0

    6.

    Shared Voting Power

     

    528,000(1)

    7.

    Sole Dispositive Power

    0

    8.

    Shared Dispositive Power

     

    528,000(1)

    9.

    Aggregate Amount Owned by Each Reporting Person

     

    528,000(1)

    10. Check Box if the Aggregate Amount in Row (9) Excludes Certain Shares  

    ☐

      

    11.

    Percent of Class Represented in Row (9)

     

    2.56%*

    12.

    Type of Reporting Person (See Instructions)

     

    IN

     

    1)Shares of Common Stock held jointly by Moises Tache Galante and his spouse, Stephannie Matz Zyman.

     

    *Based on 20,600,652 shares of Common Stock, $.001 par value per share, at August 7, 2024, as reported on the Issuer’s Form 10-Q as filed with the SEC on August 7, 2024.

     

     

     

     

    CUSIP No. 716382106 SCHEDULE 13G Page 5 of 9 Pages

     

    Item 1(a).Name of Issuer.

     

    PetMed Express, Inc.

     

    Item 1(b).Address of Issuer’s Principal Executive Offices.

     

    420 South Congress Avenue,

    Delray Beach, FL, 33445

     

    Item 2(a).Name of Person Filing.

     

    Nina Capital Holdings, Inc.

     

    Item 2(b).Address of Principal Business Office or, if None, Residence.

     

    17301 Biscayne Blvd.

    Apt 2205,

    Aventura, FL 33160

     

    Item 2(c).Citizenship.

     

    British Virgin Islands

     

    Item 2(d).Title of Class of Securities.

     

    Common Stock, $.001 par value per share ("Common Stock")

     

    Item 2(e).CUSIP Number.

     

    716382106

     

    Item 3.If this statement is filed pursuant to Rule 13d-1(b), or 13d-2(b) or (c), check whether the person filing is a:

     

    (a)☐ Broker or dealer registered under Section 15 of the Exchange Act;

     

    (b)☐ Bank as defined in Section 3(a)(6) of the Exchange Act;

     

    (c)☐ Insurance company as defined in Section 3(a)(19) of the Exchange Act;

     

    (d)☐ Investment company registered under Section 8 of the Investment Company Act.

     

    (e)☐ An investment adviser in accordance with Rule 13d-1(b)(1)(ii)(E);

     

    (f)☐ An employee benefit plan or endowment fund in accordance with Rule 13d-1(b)(1)(ii)(F);

     

    (g)☐ A parent holding company or control person in accordance with Rule 13d-1(b)(1)(ii)(G);

     

     

     

     

    CUSIP No. 716382106 SCHEDULE 13G Page 6 of 9 Pages

     

    (h)☐ A savings association as defined in Section 3(b) of the Federal Deposit Insurance Act;

     

    (i)☐ A church plan that is excluded from the definition of an investment company under Section 3(c)(14) of the Investment Company Act;

     

    (j)☐ Group, in accordance with Rule 13d-1(b)(1)(ii)(J).

     

    Not applicable.

     

    Item 4.Ownership.

     

    Provide the following information regarding the aggregate number and percentage of the class of securities of the issuer identified in Item 1.

     

    (a) Amount beneficially owned: 2,078,000(1)

     

    (b) Percent of class:

     

    10.08%(2)

     

    (c) Number of shares as to which each Reporting Person has:

     

    (i)Sole power to vote or to direct the vote:

     

    Such shares are held by the following entities in the respective amounts listed:

     

    NCH: 0

    Moises Tache Galante: 0

    Stephannie Matz Zyman: 0

     

    (ii)Shared power to vote or to direct the vote:

     

    Such shares are held by the following entities in the respective amounts listed:

     

    NCH: 1,550,000

    Moises Tache Galante: 2,078,000(1)

    Stephannie Matz Zyman: 528,000

     

    (iii)Sole power to dispose or to direct the disposition of:

     

    Such shares are held by the following entities in the respective amounts listed:

     

    NCH: 0

    Moises Tache Galante: 0

    Stephannie Matz Zyman: 0

     

    (iv)Shared power to dispose or to direct the disposition of:

     

    Such shares are held by the following entities in the respective amounts listed:

     

    NCH: 1,550,000

    Moises Tache Galante: 2,078,000(1)

    Stephannie Matz Zyman: 528,000

     

    (1)Includes (i) 1,550,000 shares of Common Stock held by Nina Capital Holdings, and (ii) 528,000 shares of Common Stock held jointly by Moises Tache Galante and his spouse, Stephannie Matz Zyman.

     

    (2)Based on 20,600,652 Common Stock outstanding as of August 7, 2024.

     

     

     

     

    CUSIP No. 716382106 SCHEDULE 13G Page 7 of 9 Pages

     

     

    Item 5.Ownership of Five Percent or Less of a Class.

     

    Not applicable.

     

    Item 6.Ownership of More than Five Percent on Behalf of Another Person.

     

    Not applicable.

     

    Item 7.Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on By the Parent Holding Company or Control Person.

     

    Not applicable.

     

    Item 8.Identification and Classification of Members of the Group.

     

    See Exhibit A attached.

     

    Item 9.Notice of Dissolution of Groups.

     

    Not applicable.

     

    Item 10.Certification.

     

    By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under § 240.14a-11.

     

     

     

     

    CUSIP No. 716382106 SCHEDULE 13G Page 8 of 9 Pages

     

    SIGNATURE

     

    After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

     

    Dated: October 10, 2024

     

      Nina Capital Holdings Inc.
         
      By: /s/ Moises Tache Galante
      Name: Moises Tache Galante
      Title: Director

     

     

     

     

    CUSIP No. 716382106 SCHEDULE 13G Page 9 of 9 Pages

     

    EXHIBIT A

     

    JOINT FILING AGREEMENT

     

    This will confirm the agreement by and among the undersigned that the Schedule 13G filed with the Securities and Exchange Commission on or about the date hereof with respect to the beneficial ownership by the undersigned of the Common Stock, par value $0.001 per share, of PetMed Express, Inc. will be filed on behalf of each of the persons and entities named below in accordance with Rule 13d-1 under the Securities Exchange Act of 1934, as amended. This Agreement may be executed in two or more counterparts, each of which shall be deemed an original, but all of which together shall constitute one and the same instrument.

     

    Dated: October 10, 2024

     

      Nina Capital Holdings Inc.
         
      By: /s/ Moises Tache Galante
      Name:  Moises Tache Galante
      Title: Director
         
      By: /s/ Moises Tache Galante
      Name: Moises Tache Galante
         
      By: /s/ Stephannie Matz Zyman
      Name: Stephannie Matz Zyman

     

     

     

     

     

    Get the next $PETS alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $PETS

    DatePrice TargetRatingAnalyst
    5/25/2023$20.00Buy
    Lake Street
    1/25/2022$25.00 → $21.00Underweight
    Morgan Stanley
    1/20/2022$32.00Neutral → Buy
    Sidoti
    11/18/2021$25.00Underweight
    Morgan Stanley
    10/1/2021$28.00Hold
    Jefferies
    8/5/2021$22.00Underperform
    Credit Suisse
    More analyst ratings

    $PETS
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    See more
    • Lake Street initiated coverage on PetMed Express with a new price target

      Lake Street initiated coverage of PetMed Express with a rating of Buy and set a new price target of $20.00

      5/25/23 9:17:49 AM ET
      $PETS
      Retail-Drug Stores and Proprietary Stores
      Consumer Staples
    • Morgan Stanley reiterated coverage on PetMed Express with a new price target

      Morgan Stanley reiterated coverage of PetMed Express with a rating of Underweight and set a new price target of $21.00 from $25.00 previously

      1/25/22 10:17:17 AM ET
      $PETS
      Retail-Drug Stores and Proprietary Stores
      Consumer Staples
    • PetMed Express upgraded by Sidoti with a new price target

      Sidoti upgraded PetMed Express from Neutral to Buy and set a new price target of $32.00

      1/20/22 9:13:56 AM ET
      $PETS
      Retail-Drug Stores and Proprietary Stores
      Consumer Staples

    $PETS
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • Wagmo Partners with PetMeds® to Bring Everyday Pet Health Savings to Members

      New partnership gives Wagmo members savings on prescriptions, supplements and everyday pet health essentials Wagmo, the pet healthcare benefit trusted by leading employers, today announced a new partnership with PetMed Express, Inc., parent company of PetMeds and PetCareRx (NASDAQ:PETS). Through this collaboration, Wagmo members now have access to exclusive savings on a wide range of pet health products, ranging from nutritional foods, tasty treats and vet-trusted medications to supplements and daily care essentials for dogs and cats. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250624773408/en/ The partnership enhances Wagm

      6/24/25 9:00:00 AM ET
      $PETS
      Retail-Drug Stores and Proprietary Stores
      Consumer Staples
    • PetMed Express, Inc. Announces Preliminary Fourth Quarter and FY 2025 Results and Filing of Form 12b-25

      DELRAY BEACH, Fla., June 16, 2025 (GLOBE NEWSWIRE) -- PetMed Express, Inc. dba PetMeds and parent company of PetCareRx (NASDAQ:PETS) today announced preliminary fourth quarter and fiscal year 2025 results and filed Form 12b-25, Notification of Late Filing, with the Securities and Exchange Commission. The Company is unable to file its Annual Report on Form 10-K for the fiscal year ended March 31, 2025 within the prescribed time period without unreasonable effort or expense. The Company expects to file its Annual Report on Form 10-K with the Securities and Exchange Commission as soon as practicable, and no later than July 1, 2025, in accordance with Rule 12b-25. Preliminary Fourth Quarter

      6/16/25 8:30:00 AM ET
      $PETS
      Retail-Drug Stores and Proprietary Stores
      Consumer Staples
    • PetMed Express, Inc. Announces Delay in Fourth Quarter and Fiscal Year End Earnings Release and Conference Call

      DELRAY BEACH, Fla., June 10, 2025 (GLOBE NEWSWIRE) -- PetMed Express, Inc. dba PetMeds and parent company of PetCareRx (NASDAQ:PETS) today announced it is delaying the release of the Company's fourth quarter and fiscal year 2025 earnings release and subsequent conference call, which had been scheduled for June 10, 2025, because the Company requires additional time to complete the year-end audit process. The Company anticipates that it will issue the earnings release, hold the related conference call, and file its Annual Report on Form 10-K as soon as possible, but no later than June 16, 2025. About PetMed Express, Inc. Founded in 1996, PetMeds is a leader in pioneering the digital pet p

      6/10/25 4:05:00 PM ET
      $PETS
      Retail-Drug Stores and Proprietary Stores
      Consumer Staples